Effects of spinally and supraspinally injected 3-isobutyl-1-methylxanthine, cholera toxin, and pertussis toxin on immobilization stress-induced antinociception in the mouse

European Neuropsychopharmacology

Volumn 13, Issue 4, 2003, Pages 281-288

  Chung, Ki M ^a   Choi, Seong S ^a   Choi, Mi R ^a   Suh, Hong W ^a  

^a Hallym University   (South Korea)

Author keywords

Antinociception; Cholera toxin; Immobilization stress; Isobutylmethylxanthine; Pertussis toxin

Indexed keywords

CHOLERA TOXIN; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOBUTYLMETHYLXANTHINE; PERTUSSIS TOXIN; PHOSPHODIESTERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; IMMOBILIZATION STRESS; INJECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; STATISTICAL SIGNIFICANCE; TAIL FLICK TEST;

EID: 0041848434     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-977X(03)00018-X     Document Type: Article

References (43)

1. Adams J.U., Andrews J.S., Hiller J.M., Simon E.J., Holtzman S.G. Effects of stress and β-funal trexamine pretreatment on morphine analgesia and opioid binding in rats. Life Sci. 41:1987;2835-2844.
2. Aloisi A.M., Ceccarelli I., Lupo C. Behavioural and hormonal effects of restraint stress and formalin test in male and female rats. Brain Res. Bull. 47:1998;57-62.
3. Aloisi A.M., Steenbergen H.L., van de Poll N.E., Farabollini F. Sex-dependent effects of restraint on nociception and pituitary-adrenal hormones in the rat. Physiol. Behav. 55:1994;789-793.
4. Bhattacharya S.K., Keshary P.R., Sanyal A.K. Immobilisation stress-induced antinociception in rats: possible role of serotonin and prostaglandins. Eur. J. Pharmacol. 50:1978;83-85.
5. Bodnar R.J., Paul D., Rosenblum M., Liu L., Pasternak G.W. Blockade of morphine analgesia by both pertussis and cholera toxins in the periaqueductal gray and locus coeruleus. Brain Res. 529:1990;324-328.
6. B receptor pharmacology. Annu. Rev. Pharmacol. Toxicol. 33:1993;109-147.
7. Calcagnetti D.J., Holtzman S.G. Factors affecting restraint stress-induced potentiation of morphine analgesia. Brain Res. 537:1990;157-162.
8. Calcagnetti D.J., Holtzman S.G. Intake of sweet water attenuates restraint-stress-induced potentiation of morphine analgesia in rats. Brain Res. Bull. 29:1992;859-864.
9. Calcagnetti D.J., Stafinsky J.L., Crisp T.A. Single restraint stress exposure potentiates analgesia induced by intrathecally administered DAGO. Brain Res. 592:1992;305-309.
10. Chung K.M., Song D.K., Suh H.W., Lee M.H., Kim Y.H. Effects of intrathecal or intracerebroventricular pretreatment with pertussis toxin on antinociception induced by β-endorphin or morphine administered intracerebroventricularly in mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 349:1994;588-593.
11. Chung K.M., Lee K.C., Song D.K., Huh S.O., Choi M.R., Kim Y.H., Suh H.W. Differential modulatory roles of cholera toxin and pertussis toxin in the regulation of pain responses induced by excitatory amino acids administered intrathecally in mice. Brain Res. 867:2000;246-249.
12. Chung K.M., Song D.K., Huh S.O., Choi M.R., Kim Y.H., Suh H.W. Effects of supraspinal and spinal GABA receptors on immobilization stress-induced antinociception in the mouse. Biogenic Amines. 15:2000;531-538.
13. D'Amore A., Chiarotti F., Renzi P. High-intensity nociceptive stimuli minimize behavioral effects induced by restraining stress during the tail-flick test. J. Pharmacol. Toxicol. Methods. 27:1992;197-201.
14. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
15. De Lima T.C., Rae G.A. Effects of cold-restraint and swim stress on convulsions induced by pentylenetetrazol and electroshock: influence of naloxone pretreatment. Pharmacol. Biochem. Behav. 40:1991;297-300.
16. DeLander G.E., Hopkins C.J. Spinal adenosine modulates descending antinociceptive pathways stimulated by morphine. J. Pharmacol. Exp. Ther. 239:1986;88-93.
17. Dunham N.W., Miya T.S. A note on a simple apparatus for detecting neurological deficit in rats and mice. J. Am. Pharm. Assoc. 46:1957;208-209.
18. Galeotti N., Ghelardini C., Bartolini A. Effect of pertussis toxin on morphine, diphenhydramine, baclofen, clomipramine and physostigmine antinociception. Eur. J. Pharmacol. 308:1996;125-133.
19. Galeotti N., Ghelardini C., Vinci M.C., Bartolini A. Role of potassium channels in the antinociception induced by agonists of α2-adrenoceptors. Br. J. Pharmacol. 126:1999;1214-1220.
20. Haley T.J., McCormick W.G. Pharmacological effects produced by intracerebral injections of drugs in the conscious mouse. Br. J. Pharmacol. 12:1957;12-15.
21. Haulica I., Busuioc A., Neamtu C., Dorneanu V., Titu G., Spac A. Possible involvement of L-arginine-nitric oxide pathway in the modulation of stress-induced analgesia. Rom. J. Physiol. 34:1997;19-24.
22. Hawes B.E., Fried S., Yao X., Weig B., Graziano M.P. Nociceptin (ORL-1) and μ-opioid receptors mediate mitogen-activated protein kinase activation in CHO cells through a Gi-coupled signaling pathway: evidence for distinct mechanisms of agonist-mediated desensitization. J. Neurochem. 71:1998;1024-1033.
23. Hoehn K., Reid A., Sawynok J. Pertussis toxin inhibits antinociception produced by intrathecal injection of morphine, noradrenaline and baclofen. Eur. J. Pharmacol. 146:1988;65-72.
24. B receptor ligands in stress-induced antinociception in male mice. Methods Find. Exp. Clin. Pharmacol. 19:1997;167-171.
25. Hylden J.L.K., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur. J. Pharmacol. 67:1980;313-316.
26. Korzeniewska I., Plaznik A. Influence of serotonergic drugs on restraint stress induced analgesia. Pol. J. Pharmacol. 47:1995;381-385.
27. Levesque D., Holtzman S.G. The potentiating effects of restraint stress and continuous naloxone infusion on the analgesic potency or morphine are additive. Brain Res. 617:1993;176-180.
28. Lipa S.M., Kavaliers M. Sex differences in the inhibitory effects of the NMDA antagonist, MK-801, on morphine and stress-induced analgesia. Brain Res. Bull. 24:1990;627-630.
29. Massi P., Rubino T., Parenti M., Giagnoni G., Groppetti A., Parolaro D. Cholera toxin antagonizes morphine-induced catalepsy through a cyclic AMP-independent mechanism. Eur. J. Pharmacol. 243:1993;65-71.
30. Miller D.B. Restraint-induced analgesia in the CD-1 mouse: interactions with morphine and time of day. Brain Res. 473:1988;327-335.
31. Nicholson D., Reid A., Sawynok J. Effects of forskolin and phosphodiesterase inhibitors on spinal antinociception by morphine. Pharmacol. Biochem. Behav. 38:1991;753-758.
32. Sanchez-Blazquez P., Garzon J. Cholera toxin and pertussis toxin on opioid- and α 2-mediated supraspinal analgesia in mice. Life Sci. 48:1991;1721-1727.
33. Satoh M., Minami M. Molecular pharmacology of the opioid receptors. Pharmacol. Ther. 68:1995;343-364.
34. Shah S., Breivogel C., Selly D., Munirathinam G., Childers S., Yoburn B.C. Time-dependent effects of in vivo pertussis toxin on morphine analgesia and G-proteins in mice. Pharmacol. Biochem. Behav. 56:1997;465-469.
35. Standifer K.M., Pasternak G.W. G proteins and opioid receptor-mediated signalling. Cell Signal. 9:1997;237-248.
36. Suh H.W., Lee B.J., Song D.K., Kim Y.H. Spinal, but not supraspinal, opioid receptors are involved in immobilization stress-induced antinociception in the mouse. Pharmacol. Commun. 5:1995;73-79.
37. Suh H.W., Sim Y.B., Choi Y.S., Song D.K., Kim Y.H. Differential effects of 3-isobutyl-1-methylxanthine injected intrathecally or intracerebroventricularly on antinociception induced by opioids administered intracerebroventricularly in the mouse. Neuropeptides. 28:1995;357-363.
38. Suh H.W., Song D.K., Sim Y.B., Choi Y.S., Kim Y.H. Effect of intrathecal or intracerebroventricular pretreatment with cholera toxin on antinociception induced by opioids administered intracerebroventricularly in mice. Pharmacol. Commun. 6:1995;187-194.
39. Suh H.W., Song D.K., Kwon S.H., Kim K.W., Min B.H., Kim Y.H. Effects of spinally and supraspinally injected 3-isobutyl-1-methylxanthine, cholera toxin, and pertussis toxin on cold water swimming stress-induced antinociception in the mouse. Gen. Pharmacol. 28:1997;607-610.
40. Tseng L.F., Collins K.A. Pretreatment with pertussis toxin differentially modulates morphine- and β-endorphin-induced antinociception in the mouse. J. Pharmacol. Exp. Ther. 279:1996;39-46.
41. Womer D.E., DeLapp N.W., Shannon H.E. Intrathecal pertussis toxin produces hyperalgesia and allodynia in mice. Pain. 70:1997;223-228.
42. Woolfolk D.R., Holtzman S.G. Restraint stress potentiates analgesia induced by 5′-N-ethylcarboxamidoadenosine: comparison with morphine. Eur. J. Pharmacol. 239:1993;177-182.
43. Woolfolk D.R., Holtzman S.G. Rat strain differences in the potentiation of morphine-induced analgesia by stress. Pharmacol. Biochem. Behav. 51:1995;699-703.